Exclusive in-licensing agreement with Vaxinano

AI SummaryClose X

Eco Animal Health Group plc has entered into a perpetual exclusive license agreement with Vaxinano SAS for a late-stage sheep vaccine candidate against toxoplasmosis, a disease causing significant economic losses through reproductive failure. This agreement, which includes a modest upfront fee, a future development milestone payment, and royalties based on sales, will be funded from operating cashflow and is within the current R&D budget. The company anticipates peak annual sales of approximately £10 million in the UK and Europe alone, expecting this de-risked and accelerated pathway to market entry to contribute meaningfully to its growing vaccine portfolio.

Disclaimer*

UK 100

Latest directors dealings